Evidence mapPaperPMID 41155348Full record

ArticleInternational journal of molecular sciences2025

Smaranda Ioana Mitran, Mădălina Iuliana Muşat, Cornelia Bejenaru, George Dan Mogoşanu, Ianis Kevyn Ştefan Boboc, Robertina-Iulia Tudoraşcu, Georgică Târtea, Ovidiu Mircea Zlătian, Antonia Blendea, Andrei Biţă and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Smaranda Ioana MitranExperimental Research Centre for Normal and Pathological Aging, University of Medicine and Pharmacy of Craiova, 2 Petru Rareş Street, 200349 Craiova, Romania.
Mădălina Iuliana MuşatExperimental Research Centre for Normal and Pathological Aging, University of Medicine and Pharmacy of Craiova, 2 Petru Rareş Street, 200349 Craiova, Romania.
Cornelia BejenaruDrug Research Center, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, 2 Petru Rareş Street, 200349 Craiova, Romania.ORCID 0009-0009-3923-0018
George Dan MogoşanuDrug Research Center, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, 2 Petru Rareş Street, 200349 Craiova, Romania.ORCID 0000-0001-6338-9277
Ianis Kevyn Ştefan BobocExperimental Research Centre for Normal and Pathological Aging, University of Medicine and Pharmacy of Craiova, 2 Petru Rareş Street, 200349 Craiova, Romania.ORCID 0000-0002-8516-9766
Robertina-Iulia TudoraşcuDepartment of Pathophysiology, University of Medicine and Pharmacy of Craiova, 2 Petru Rareş Street, 200349 Craiova, Romania.ORCID 0009-0008-4127-0978
Georgică TârteaDepartment of Physiology, University of Medicine and Pharmacy of Craiova, 2 Petru Rareş Street, 200349 Craiova, Romania.
Ovidiu Mircea ZlătianDepartment of Microbiology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 1 May Avenue, 200638 Craiova, Romania.ORCID 0000-0003-3510-3838
Antonia BlendeaDrug Research Center, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, 2 Petru Rareş Street, 200349 Craiova, Romania.ORCID 0000-0002-3448-2736
Andrei BiţăDrug Research Center, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, 2 Petru Rareş Street, 200349 Craiova, Romania.ORCID 0000-0003-4715-1423
Adina-Elena SegneanuInstitute for Advanced Environmental Research, West University of Timişoara (ICAM-WUT), 4 Oituz Street, 300086 Timişoara, Romania.ORCID 0000-0002-1623-8094
Ludovic Everard BejenaruDrug Research Center, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, 2 Petru Rareş Street, 200349 Craiova, Romania.ORCID 0009-0004-1778-7011

Funding

University of Medicine and Pharmacy of Craiova 26/725/11/25.07.2024
6 · The paper itself

Abstract

Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as a systemic condition with neuropsychiatric comorbidities, including depression. Growing evidence for the neuroprotective, antidepressant, and anxiolytic potential of

Indexed as

DepressionNeuronal PlasticityNon-alcoholic Fatty Liver DiseasePlant ExtractsPortulacaAnimalsAnxietyAstrocytesBehavior, AnimalCholine DeficiencyDietDisease Models, AnimalFemaleHippocampusMaleMethionineMethioninePlant ExtractsCUMSdepressionMCMCDNAFLDneurogenesisneuroprotectionPortulaca oleracea

Identifiers

PMID41155348
PMCPMC12564810

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.